Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
CALL
3D Systems Corp
DDD
$518M
| $28.9M | 0.01% |
1,610,300
+820,600
| +104% | +$12.3M |
|
777
PUT
F5
FFIV
$21.5B
| $28.9M | 0.01% |
231,600
-58,900
| -20% | -$7.15M |
|
778
CALL
Murphy Oil
MUR
$5.16B
| $28.9M | 0.01% |
949,500
-109,000
| -10% | -$3.11M |
|
779
CALL
RH
RH
$2.71B
| $28.9M | 0.01% |
834,300
+237,100
| +40% | +$7.55M |
|
780
CALL
Incyte
INCY
$25.9B
| $28.8M | 0.01% |
305,800
-1,300
| -0.4% | -$110K |
|
|
VMW
781
DELISTED
VMware, Inc
VMW
| $28.7M | 0.01% |
391,887
-1,059,033
| -73% | -$74.5M |
|
782
PUT
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $28.7M | 0.01% |
763,800
-73,400
| -9% | -$2.73M |
|
|
WWAV
783
CALL
DELISTED
The WhiteWave Foods Company
WWAV
| $28.7M | 0.01% |
527,800
-42,000
| -7% | -$2.31M |
|
784
CALL
Baxter International
BAX
$13.7B
| $28.7M | 0.01% |
602,500
-210,800
| -26% | -$9.94M |
|
785
PUT
Precigen
PGEN
$2.57B
| $28.6M | 0.01% |
1,030,593
+478,065
| +87% | +$12.6M |
|
|
INVN
786
PUT
DELISTED
Invensense Inc
INVN
| $28.5M | 0.01% |
3,847,000
-172,700
| -4% | -$1.22M |
|
|
FL
787
CALL
DELISTED
Foot Locker
FL
| $28.5M | 0.01% |
421,400
+73,400
| +21% | +$4.58M |
|
788
PUT
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$670M
| $28.5M | 0.01% |
29,215
+15,565
| +114% | +$12.8M |
|
789
CALL
Copa Holdings
CPA
$5.95B
| $28.4M | 0.01% |
323,300
+167,000
| +107% | +$12.7M |
|
790
PUT
Akamai
AKAM
$15.2B
| $28.4M | 0.01% |
535,400
+311,300
| +139% | +$16.7M |
|
|
IOC
791
PUT
DELISTED
Interoil Corporation
IOC
| $28.3M | 0.01% |
556,400
-14,000
| -2% | -$686K |
|
792
PUT
Cirrus Logic
CRUS
$5.6B
| $28.3M | 0.01% |
532,800
+151,600
| +40% | +$7.29M |
|
793
CALL
Clorox
CLX
$13B
| $28.3M | 0.01% |
226,200
-46,500
| -17% | -$6.09M |
|
|
794
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $28.3M | 0.01% |
752,400
-82,800
| -10% | -$3.08M |
|
795
CALL
AstraZeneca
AZN
$259B
| $28.2M | 0.01% |
429,300
+92,350
| +27% | +$6.04M |
|
796
CALL
Dollar General
DG
$27.6B
| $28.2M | 0.01% |
403,100
+104,500
| +35% | +$8.85M |
|
|
WFM
797
DELISTED
Whole Foods Market Inc
WFM
| $28.1M | 0.01% |
991,005
-854,119
| -46% | -$26.3M |
|
798
PUT
Pultegroup
PHM
$24.7B
| $28M | 0.01% |
1,394,800
-10,000
| -0.7% | -$207K |
|
799
CALL
Dominion Energy
D
$58.6B
| $27.9M | 0.01% |
376,100
+30,900
| +9% | +$2.35M |
|
800
CALL
Canadian Pacific Kansas City
CP
$83.2B
| $27.8M | 0.01% |
911,000
-154,500
| -15% | -$4.54M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.